References
- Berenson, R. A., & Rice, T. (2015). Beyond measurement and reward: Methods of motivating quality improvement and accountability. Health Services Research, 50(Suppl 2), 2155–2186.
- Briesacher, B. A., Soumerai, S. B., Field, T. S., Fouayzi, H., & Gurwitz, J. H. (2009). Nursing home residents and enrollment in medicare part D. Journal of the American Geriatrics Society, 57(10), 1902–1907.
- Gerontological Advanced Practice Nurses Association. (2017). Joint summary statement diagnosing schizophrenia in skilled nursing centers. Accessed June 29, 2017, from https://www.gapna.org/sites/default/files/documents/schizophrenia-statement.pdf. Published January 11, 2017.
- Gurwitz, J. H., Bonner, A., & Berwick, D. M. (2017). Reducing excessive use of antipsychotic agents in Nursing homes. JAMA, 318(2), 118–119.
- Harris-Kojetin, L., Sengupta, M., Park-Lee, E., Valverde, R., Caffrey, C., Rome, V., & Lendon, J. (2016). Long-term care providers and services users in the United States: Data from the national study of long-term care providers, 2013–2014. Vital Health Statistics, 3, (38), x–xii.
- Kuehn, B. M. (2013). Efforts stall to curb nursing home antipsychotic use. JAMA, 310(11), 1109–1110.
- Maust, D. T., Kim, H. M., Chiang, C., & Kales, H. C. (2018). Association of the centers for medicare & medicaid services’ national partnership to improve dementia care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014. JAMA Internal Medicine, 178(5), 640–647.
- Morris, J. N., Fries, B. E., & Morris, S. A. (1999). Scaling ADLs within the MDS. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 54(11), M546–M553.
- Nursing Home Compare Datasets. Baltimore, MD: Data.Medicare.gov; (2018) https://data.medicare.gov/data/nursing-home-compare.
- RTI International. (2017). Skilled nursing facility quality reporting program measure calculations and reporting user's manual. Accessed May 22, 2017, from https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/NursingHomeQualityInits/Downloads/SNF-QM-Users-Manual-V10-FINAL-5-22-17.pdf.
- Shadish, W. R., Cook, T. D., & Campbell, D. T. (2002). Experimental and quasi-experimental designs for generalized causal inference. New York: Houghton Mifflin Company.
- Thomas, K. S., Dosa, D., Wysocki, A., & Mor, V. (2017). The minimum data set 3.0 cognitive function scale. Medical Care, 55(9), e68–e72.
- Winter, J. D., Kerns, J. W., Winter, K. M., & Sabo, R. T. (2017). Increased reporting of exclusionary diagnoses inflate apparent reductions in long-stay antipsychotic prescribing. Clinical Gerontologist,1–5. doi:10.1080/07317115.2017.1395378